BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 07/12/2010

FDA Clears AUGMENTIN Drug Products for Sale, Citing Lack of Safety or Effectiveness Concerns

The FDA has determined that AUGMENTIN drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving ANDA applications that refer to these products.

Source: Federal Register — Health and Human ServicesOpen original release →